160 related articles for article (PubMed ID: 19010263)
1. Human papillomavirus in HNSCC: recognition of a distinct disease type.
Vidal L; Gillison ML
Hematol Oncol Clin North Am; 2008 Dec; 22(6):1125-42, vii. PubMed ID: 19010263
[TBL] [Abstract][Full Text] [Related]
2. Gene expression profiles in HPV-infected head and neck cancer.
Schlecht NF; Burk RD; Adrien L; Dunne A; Kawachi N; Sarta C; Chen Q; Brandwein-Gensler M; Prystowsky MB; Childs G; Smith RV; Belbin TJ
J Pathol; 2007 Nov; 213(3):283-93. PubMed ID: 17893858
[TBL] [Abstract][Full Text] [Related]
3. Distinct risk factor profiles for human papillomavirus type 16-positive and human papillomavirus type 16-negative head and neck cancers.
Gillison ML; D'Souza G; Westra W; Sugar E; Xiao W; Begum S; Viscidi R
J Natl Cancer Inst; 2008 Mar; 100(6):407-20. PubMed ID: 18334711
[TBL] [Abstract][Full Text] [Related]
4. [Involvement of human papillomavirus in upper aero-digestive tracts cancers].
Neufcoeur PE; Arafa M; Delvenne P; Saussez S
Bull Cancer; 2009 Oct; 96(10):941-50. PubMed ID: 19744917
[TBL] [Abstract][Full Text] [Related]
5. [Human papillomavirus type 16 E6 oncogene and expression of P53, RB and PCNA in human cervical carcinoma].
Bian J; Yu X; Dong J; Zhao W; Zhou Y; Luan Y
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 1997 Sep; 11(3):271-3. PubMed ID: 15617346
[TBL] [Abstract][Full Text] [Related]
6. Genome-wide DNA copy number alterations in head and neck squamous cell carcinomas with or without oncogene-expressing human papillomavirus.
Smeets SJ; Braakhuis BJ; Abbas S; Snijders PJ; Ylstra B; van de Wiel MA; Meijer GA; Leemans CR; Brakenhoff RH
Oncogene; 2006 Apr; 25(17):2558-64. PubMed ID: 16314836
[TBL] [Abstract][Full Text] [Related]
7. Human papillomavirus type 16 in head and neck carcinogenesis.
Chen R; Aaltonen LM; Vaheri A
Rev Med Virol; 2005; 15(6):351-63. PubMed ID: 15942978
[TBL] [Abstract][Full Text] [Related]
8. p53 codon 72 polymorphisms in human papillomavirus-negative and human papillomavirus-positive squamous cell carcinomas of the oropharynx.
Perrone F; Mariani L; Pastore E; Orsenigo M; Suardi S; Marcomini B; DaRiva L; Licitra L; Carbone A; Pierotti MA; Pilotti S
Cancer; 2007 Jun; 109(12):2461-5. PubMed ID: 17492690
[TBL] [Abstract][Full Text] [Related]
9. Viral interaction: a possible contributing factor in head and neck cancer progression.
Underbrink MP; Hoskins SL; Pou AM; Albrecht T
Acta Otolaryngol; 2008; 128(12):1361-9. PubMed ID: 18607925
[TBL] [Abstract][Full Text] [Related]
10. High-risk human papillomavirus (HPV) is not associated with p53 and bcl-2 expression in oral squamous cell carcinomas.
Oliveira MC; Soares RC; Pinto LP; Souza LB; Medeiros SR; Costa Ade L
Auris Nasus Larynx; 2009 Aug; 36(4):450-6. PubMed ID: 19124208
[TBL] [Abstract][Full Text] [Related]
11. Human papillomavirus infection in oral verrucous carcinoma: genotyping analysis and inverse correlation with p53 expression.
Fujita S; Senba M; Kumatori A; Hayashi T; Ikeda T; Toriyama K
Pathobiology; 2008; 75(4):257-64. PubMed ID: 18580072
[TBL] [Abstract][Full Text] [Related]
12. Comparative analysis of 19 genital human papillomavirus types with regard to p53 degradation, immortalization, phylogeny, and epidemiologic risk classification.
Hiller T; Poppelreuther S; Stubenrauch F; Iftner T
Cancer Epidemiol Biomarkers Prev; 2006 Jul; 15(7):1262-7. PubMed ID: 16835321
[TBL] [Abstract][Full Text] [Related]
13. A single-codon mutation converts HPV16 E6 oncoprotein into a potential tumor suppressor, which induces p53-dependent senescence of HPV-positive HeLa cervical cancer cells.
Ristriani T; Fournane S; Orfanoudakis G; Travé G; Masson M
Oncogene; 2009 Feb; 28(5):762-72. PubMed ID: 19015633
[TBL] [Abstract][Full Text] [Related]
14. Significance of human papillomavirus 16/18 infection in association with p53 mutation in lung carcinomas.
Yu Y; Yang A; Hu S; Zhang J; Yan H
Clin Respir J; 2013 Jan; 7(1):27-33. PubMed ID: 22171791
[TBL] [Abstract][Full Text] [Related]
15. New evidence for geographic variation in the role of human papillomavirus in tonsillar carcinogenesis.
Li W; Tran N; Lee SC; O'Brien CJ; Tse GM; Scolyer RA; Hong A; Milross C; Yu KH; Rose BR
Pathology; 2007 Apr; 39(2):217-22. PubMed ID: 17454751
[TBL] [Abstract][Full Text] [Related]
16. Association between p53 and human papillomavirus in head and neck cancer survival.
Smith EM; Wang D; Rubenstein LM; Morris WA; Turek LP; Haugen TH
Cancer Epidemiol Biomarkers Prev; 2008 Feb; 17(2):421-7. PubMed ID: 18268127
[TBL] [Abstract][Full Text] [Related]
17. Cancer. HPV casts a wider shadow.
Zelkowitz R
Science; 2009 Jan; 323(5914):580-1. PubMed ID: 19179508
[No Abstract] [Full Text] [Related]
18. E6 and e7 gene silencing and transformed phenotype of human papillomavirus 16-positive oropharyngeal cancer cells.
Rampias T; Sasaki C; Weinberger P; Psyrri A
J Natl Cancer Inst; 2009 Mar; 101(6):412-23. PubMed ID: 19276448
[TBL] [Abstract][Full Text] [Related]
19. Immune response during therapy with cisplatin or radiation for human papillomavirus-related head and neck cancer.
Spanos WC; Nowicki P; Lee DW; Hoover A; Hostager B; Gupta A; Anderson ME; Lee JH
Arch Otolaryngol Head Neck Surg; 2009 Nov; 135(11):1137-46. PubMed ID: 19917928
[TBL] [Abstract][Full Text] [Related]
20. TGF-beta1 and IL-4 downregulate human papillomavirus-16 oncogene expression but have differential effects on the malignant phenotype of cervical carcinoma cells.
Donalisio M; Cornaglia M; Landolfo S; Lembo D
Virus Res; 2008 Mar; 132(1-2):253-6. PubMed ID: 18206261
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
